Clinical Trial Update: Vaccination of Patients With Stage IV Melanoma With Dendritic Cells [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on vaccination of stage IV melanoma patients with dendritic cell vaccines (Phase 1/Phase 2) with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dendritic cell vaccine

Snippet

Sponsor: Baylor Research Institute | Conditions: Melanoma, Neoplasm Metastasis | Phase 1, Phase 2 | Status: COMPLETED